Protein Kinase C (PKC) Isozymes and Cancer. (4th May 2014)

• Record Type: Journal Article
• Authors: Kang, Jeong-Hun
• Other Names: Hajduch Eric Academic Editor.
• Is Part Of: New journal of science. Volume 2014(2014)
• Publication Date: 2014-05-04
• Subjects: Life sciences -- Periodicals; Life sciences; Electronic journals; Periodicals; 500
• DOI: 10.1155/2014/231418
• Languages: English
• ISSNs: 2356-7740

Abstract

Abstract : Protein kinase C (PKC) is a family of phospholipid-dependent serine/threonine kinases, which can be further classified into three PKC isozymes subfamilies: conventional or classic, novel or nonclassic, and atypical. PKC isozymes are known to be involved in cell proliferation, survival, invasion, migration, apoptosis, angiogenesis, and drug resistance. Because of their key roles in cell signaling, PKC isozymes also have the potential to be promising therapeutic targets for several diseases, such as cardiovascular diseases, immune and inflammatory diseases, neurological diseases, metabolic disorders, and multiple types of cancer. This review primarily focuses on the activation, mechanism, and function of PKC isozymes during cancer development and progression.